Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand

Nicolas Salvadori, Gonzague Jourdain, Rungroj Krittayaphong, Taweegrit Siripongboonsitti, Subsai Kongsaengdao, Kriangsak Atipornwanich, Parichart Sakulkonkij, Nasikarn Angkasekwinai, Rujipas Sirijatuphat, Sarunyou Chusri, Tanavit Mekavuthikul, Anucha Apisarnthanarak, Sirawat Srichatrapimuk, Somnuek Sungkanuparph, Suppachok Kirdlarp, Thanyakamol Phongnarudech, Suraphan Sangsawang, Panuwat Napinkul, Jullapong Achalapong, Suwimon Khusuwan, Piyanut Pratipanawat, Pornboonya Nookeu, Namphol Danpipat, Pornvimol Leethong, Piya Hanvoravongchai, Pra-ornsuda Sukrakanchana, Prasert Auewarakul

Open source

DOI: 10.1016/j.ijid.2024.107021
Published: 2024-06
Container: International Journal of Infectious Diseases
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijid.2024.107021,
  title = {Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand},
  author = {Nicolas Salvadori and Gonzague Jourdain and Rungroj Krittayaphong and Taweegrit Siripongboonsitti and Subsai Kongsaengdao and Kriangsak Atipornwanich and Parichart Sakulkonkij and Nasikarn Angkasekwinai and Rujipas Sirijatuphat and Sarunyou Chusri and Tanavit Mekavuthikul and Anucha Apisarnthanarak and Sirawat Srichatrapimuk and Somnuek Sungkanuparph and Suppachok Kirdlarp and Thanyakamol Phongnarudech and Suraphan Sangsawang and Panuwat Napinkul and Jullapong Achalapong and Suwimon Khusuwan and Piyanut Pratipanawat and Pornboonya Nookeu and Namphol Danpipat and Pornvimol Leethong and Piya Hanvoravongchai and Pra-ornsuda Sukrakanchana and Prasert Auewarakul},
  year = {2024},
  journal = {International Journal of Infectious Diseases},
  doi = {10.1016/j.ijid.2024.107021},
  url = {https://doi.org/10.1016/j.ijid.2024.107021}
}

RIS

TY  - JOUR
TI  - Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand
AU  - Nicolas Salvadori
AU  - Gonzague Jourdain
AU  - Rungroj Krittayaphong
AU  - Taweegrit Siripongboonsitti
AU  - Subsai Kongsaengdao
AU  - Kriangsak Atipornwanich
AU  - Parichart Sakulkonkij
AU  - Nasikarn Angkasekwinai
AU  - Rujipas Sirijatuphat
AU  - Sarunyou Chusri
AU  - Tanavit Mekavuthikul
AU  - Anucha Apisarnthanarak
AU  - Sirawat Srichatrapimuk
AU  - Somnuek Sungkanuparph
AU  - Suppachok Kirdlarp
AU  - Thanyakamol Phongnarudech
AU  - Suraphan Sangsawang
AU  - Panuwat Napinkul
AU  - Jullapong Achalapong
AU  - Suwimon Khusuwan
AU  - Piyanut Pratipanawat
AU  - Pornboonya Nookeu
AU  - Namphol Danpipat
AU  - Pornvimol Leethong
AU  - Piya Hanvoravongchai
AU  - Pra-ornsuda Sukrakanchana
AU  - Prasert Auewarakul
PY  - 2024
JO  - International Journal of Infectious Diseases
DO  - 10.1016/j.ijid.2024.107021
UR  - https://doi.org/10.1016/j.ijid.2024.107021
ER  -

APA

Salvadori, N., Jourdain, G., Krittayaphong, R., Siripongboonsitti, T., Kongsaengdao, S., Atipornwanich, K., Sakulkonkij, P., Angkasekwinai, N., Sirijatuphat, R., Chusri, S., Mekavuthikul, T., Apisarnthanarak, A., Srichatrapimuk, S., Sungkanuparph, S., Kirdlarp, S., Phongnarudech, T., Sangsawang, S., Napinkul, P., Achalapong, J., Khusuwan, S., Pratipanawat, P., Nookeu, P., Danpipat, N., Leethong, P., Hanvoravongchai, P., Sukrakanchana, P., & Auewarakul, P. (2024). Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2024.107021

Source records

crossref · retrieved 2026-09-26T15:17:02.741Z